For his longstanding scientific accomplishments in the breast cancer, leukemia, and lymphoma field. Dr. Cavalli brilliant clinical investigations on VP-16 paved the way for cancer treatments and his scientific contributions led the development of multiple therapeutics including, cisplatin, carboplatin, and Paclitaxel. Additionally, his leadership was pivotal to improve global cancer care establishing several initiatives and organizations that continue to propel the cancer research field forward.
To learn more please visit the press release.